During the past decade, San Francisco Clinical Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 14 clinical trials were completed, i.e. on average, 155.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Francisco Clinical Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "TauRx Therapeutics Ltd" with 3 trials sponsored and "Bellus Health Inc" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Francisco Clinical Research Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Clinvest" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "San Francisco Clinical Research Center" are "Alzheimer's Disease" (19 trials), "Migraine" (5 trials), "Migraine Headache" (5 trials), "Alzheimer Disease" (4 trials) and "Episodic Cluster Headache" (2 trials). Many other conditions were trialed in "San Francisco Clinical Research Center" in a lesser frequency.

Most popular intervention types in "San Francisco Clinical Research Center" are "Drug" (40 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "placebo" (3 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Civamide (Zucapsaicin)" (2 trials). Other intervention names were less common.

The vast majority of trials in "San Francisco Clinical Research Center" are 41 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "San Francisco Clinical Research Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in San Francisco Clinical Research Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in San Francisco Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".